Strategy for Eliminating Gastric Cancer in Japan

Helicobacter

Volumn 15, Issue 6, 2010, Pages 486-490

  Asaka, Masahiro ^a   Kato, Mototsugu ^a   Graham, David Y ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Eradication; Gastric cancer prevention; Helicobacter pylori

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RISK; CANCER SCREENING; HEALTH CARE PLANNING; HELICOBACTER INFECTION; HUMAN; INFECTION CONTROL; JAPAN; PRIORITY JOURNAL; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PEPSINOGENS; STOMACH NEOPLASMS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 78349236169     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2010.00799.x     Document Type: Article

References (22)

1. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-7.
2. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010;15:1-20.
3. Asaka M. Helicobacter pylori infection and gastric cancer. Intern Med 2002;41:1-6.
4. Koinuma N, Ogata T, Misawa J. Pharmacoeconomic assessment of gastric cancer treatment(In Japanese). Nippon Rinsho 2008;66:639-52.
5. Asaka M, Kato M, Graham D. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010;49:633-6.
6. Fukao A, Tsubono Y, Tsuji I, et al. The evaluation of screening for gastric cancer in Miyagi prefecture, Japan: a population-based case-control study. Int J Cancer 1995;60:45-8.
7. Monthly report in Japan Cancer Society 2010:558:1-2.
8. Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008;38:259-67.
9. Inui S, Yoshikawa M, Abe J, et al. Use of Helicobacter pylori testing in population-based mass screening: gastric cancer risk screening by simultaneous serum pepsinogen and Helicobacter pylori antibody testing. Helicobacter Res 2007;11:554-61.
10. Number and proportion of deaths from cancer by site affected in different age groups in 2006 (In Japanese). In: Kato H, eds. Statistics on Cancer in Japan 2008, Foundation for Promotion of Cancer Research, 2008; 62-3.
11. Incidence rate of cancer by site affected in different age groups in 2002 (In Japanese). In: Kato H, eds. Statistics on Cancer in Japan 2008, Foundation for Promotion of Cancer Research, 2008: 74-5.
12. Asaka M, Sugiyama T, Nobuta A, et al. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001;6:294-9.
13. Asaka M. Extermination of gastric cancer from Japan (In Japanese). Nippon Shokakibyo Gakkai Zasshi 2010;107:359-64.
14. Miki K, Ichinose M, Kasai N, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol 1995;362:139-43.
15. Kondoi A, Yoshihara M, Sumii K, et al. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995;30:452-60.
16. Fujishiro M, Oka M, Yahagi N, et al. Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer. J Exp Clin Cancer Res 2006;25:207-12.
17. Kang JM, Kim N, Yoo JY, et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter 2008;13:146-56.
18. Inoue K. Procedures for testing for Helicobacter pylori infection in medical check-up. Helicobacter Res 2007;11:562-7.
19. Yanaoka K, Oka M, Yoshimura N, et al. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 2008;125:917-26.
20. Ohta H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
21. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010;45:1-8.
22. Shiroiwa T, Fukuda T, Tsutani K. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan. Clin Ther 2007;29:2256-67.